Inventiva S.A. American Depository Shares (IVA) is a publicly traded Healthcare sector company. As of May 21, 2026, IVA trades at $5.14 with a market cap of $1.05B and a P/E ratio of 0.00. IVA moved +4.79% today. Year to date, IVA is +11.74%; over the trailing twelve months it is +63.17%. Its 52-week range spans $1.60 to $7.98. Analyst consensus is strong buy with an average price target of $15.75. Rallies surfaces IVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inventiva secures EUR230.9M cash ahead of delayed Q4 2026 NATIV-3 readout: Inventiva reports sub-30% dropout in NATIV-3 with 800mg dose projected to match 1,200mg tolerability over time and aims for 18% fibrosis improvement in F3 diabetic MASH patients. The top-line readout has been pushed to Q4 2026, with funding tranches tied to positive results and EUR230.9M cash on hand.
| Metric | Value |
|---|---|
| Price | $5.14 |
| Market Cap | $1.05B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.98 |
| 52-Week Low | $1.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover IVA: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.75.